Group One Trading’s ResMed RMD Stock Holding History

Group One Trading’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.38M	Sell	28,400 -50,500	-64%	-$12.6M	0.01%	1124
2025 Q4	$19M	Buy	78,900 +7,900	+11%	+$2.02M	0.03%	578
2025 Q3	$19.4M	Buy	71,000 +12,700	+22%	+$3.47M	0.03%	509
2025 Q2	$15M	Sell	58,300 -336,000	-85%	-$80.1M	0.03%	578
2025 Q1	$88.3M	Buy	394,300 +15,200	+4%	+$3.55M	0.26%	56
2024 Q4	$86.7M	Buy	379,100 +361,700	+2,079%	+$87.1M	0.2%	68
2024 Q3	$4.25M	Sell	17,400 -4,600	-21%	-$1.03M	0.01%	1122
2024 Q2	$4.21M	Buy	22,000 +18,800	+588%	+$3.81M	0.02%	916
2024 Q1	$634K	Buy	+3,200	New	+$586K	﹤0.01%	2507
2023 Q3	–	Sell	-300	Closed	-$65.5K	–	8190
2023 Q2	$65.5K	Buy	+300	New	+$66.9K	﹤0.01%	5024
2022 Q2	–	Sell	-2,400	Closed	-$582K	–	8417
2022 Q1	$582K	Hold	2,400	–	–	﹤0.01%	3650
2021 Q4	$625K	Sell	2,400 -500	-17%	-$130K	﹤0.01%	3865
2021 Q3	$764K	Sell	2,900 -1,400	-33%	-$383K	﹤0.01%	3709
2021 Q2	$1.06M	Buy	4,300 +4,200	+4,200%	+$883K	﹤0.01%	3343
2021 Q1	$19K	Sell	100 -19,000	-99%	-$3.81M	﹤0.01%	6780
2020 Q4	$4.06M	Sell	19,100 -21,100	-52%	-$4.21M	0.01%	1442
2020 Q3	$6.89M	Buy	40,200 +31,600	+367%	+$5.84M	0.02%	708
2020 Q2	$1.65M	Buy	8,600 +7,500	+682%	+$1.23M	0.01%	1612
2020 Q1	$162K	Buy	+1,100	New	+$175K	﹤0.01%	2919
2019 Q2	–	Sell	-15,000	Closed	-$1.56M	–	5326
2019 Q1	$1.56M	Buy	+15,000	New	+$1.55M	0.02%	1091
2018 Q4	–	Sell	-200	Closed	-$23K	–	5328
2018 Q3	$23K	Sell	200 -1,200	-86%	-$131K	﹤0.01%	4345
2018 Q2	$145K	Buy	+1,400	New	+$142K	﹤0.01%	3302
2017 Q3	–	Sell	-11,200	Closed	-$872K	–	5102
2017 Q2	$872K	Sell	11,200 -13,000	-54%	-$930K	0.01%	1561
2017 Q1	$1.74M	Buy	24,200 +9,800	+68%	+$677K	0.02%	955
2016 Q4	$894K	Buy	14,400 +9,900	+220%	+$606K	0.01%	1380
2016 Q3	$292K	Sell	4,500 -5,800	-56%	-$386K	﹤0.01%	2207
2016 Q2	$651K	Sell	10,300 -20,100	-66%	-$1.18M	0.01%	1547
2016 Q1	$1.76M	Sell	30,400 -4,300	-12%	-$243K	0.02%	845
2015 Q4	$1.86M	Sell	34,700 -700	-2%	-$39.5K	0.02%	902
2015 Q3	$1.8M	Buy	35,400 +2,600	+8%	+$140K	0.02%	853
2015 Q2	$1.85M	Buy	32,800 +32,300	+6,460%	+$2.04M	0.03%	801
2015 Q1	$36K	Sell	500 -4,800	-91%	-$312K	﹤0.01%	3557
2014 Q4	$297K	Buy	+5,300	New	+$277K	﹤0.01%	1970
2014 Q2	–	Sell	-1,300	Closed	-$58K	–	5449
2014 Q1	$58K	Sell	1,300 -10,400	-89%	-$467K	﹤0.01%	3521
2013 Q4	$551K	Sell	11,700 -23,500	-67%	-$1.19M	0.01%	1594
2013 Q3	$1.86M	Buy	35,200 +33,300	+1,753%	+$1.62M	0.04%	607
2013 Q2	$86K	Buy	+1,900	New	+$90.1K	﹤0.01%	2954

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Group One Trading's RMD Position: Q1 2026 in Review

Group One Trading increased its ResMed (RMD) stake by 944% in Q1 2026, buying an estimated $353K and bringing the position to 1,566 shares worth $352K. The position accounts for ﹤0.01% of the portfolio, ranked #3661.

Group One Trading first reported a position in RMD in Q4 2013 and has held it in 25 quarters since. The position peaked at $2.49M in Q3 2020. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Group One Trading held 1,566 shares of ResMed worth $352K as of Q1 2026.
Group One Trading bought 1,416 ResMed shares in Q1 2026, an estimated $353K.
ResMed made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #3661 holding.
Group One Trading first reported a position in ResMed in Q4 2013 and has held it in 25 quarters since.
Group One Trading's ResMed position peaked at $2.49M in Q3 2020.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.